82 related articles for article (PubMed ID: 3671417)
1. Antiemetic effects of metoclopramide (M) continuous infusion (CI): safety, efficacy, patient preference, and cost reduction.
Presant CA; Wiseman C; Gala K; Kennedy P; Bouzaglou A; Blayney D; Schindler J; Rigas M; Melville J; Dolan J
Prog Clin Biol Res; 1987; 248():299-302. PubMed ID: 3671417
[No Abstract] [Full Text] [Related]
2. Continuous infusion metoclopramide: clinical trials, pharmacokinetic considerations and cost-effectiveness.
Parashos PJ; Dugan WM; Fry MW
Prog Clin Biol Res; 1987; 248():303-11. PubMed ID: 3118389
[No Abstract] [Full Text] [Related]
3. Evaluation of ethanol as an antiemetic in patients receiving cisplatin.
Spiess JL; Adelstein DJ; Hines JD
Clin Ther; 1987; 9(4):400-4. PubMed ID: 3607821
[TBL] [Abstract][Full Text] [Related]
4. Prochlorperazine and transdermal scopolamine added to a metoclopramide antiemetic regimen. A controlled comparison.
Malone JM; Christensen CW; Yashinsky D; Malviya VK; Deppe G
J Reprod Med; 1990 Oct; 35(10):932-4. PubMed ID: 2246759
[TBL] [Abstract][Full Text] [Related]
5. Comparison of continuous and intermittent bolus infusions of metoclopramide during 5-day continuous intravenous infusion with cisplatin.
Mori K; Saitou Y; Tominaga K; Yokoi ; Miyazawa N
Eur J Cancer; 1991; 27(6):729-32. PubMed ID: 1648944
[TBL] [Abstract][Full Text] [Related]
6. [Cisplatin drug therapy. Antiemetic treatment. Experiences with the use of high-dose metoclopramide combined with chlopromazine and prochlorperazine].
Aasebø U; Myhr K
Tidsskr Nor Laegeforen; 1985 Jan; 105(2):148-9. PubMed ID: 4038825
[No Abstract] [Full Text] [Related]
7. Maintenance of antiemetic effect of a metoclopramide-dexamethasone combination during subsequent cisplatin courses.
Cognetti F; Carlini P; Pinnarò P; Ruggeri EM; Caporali C
Oncology; 1986; 43(5):292-4. PubMed ID: 3763123
[TBL] [Abstract][Full Text] [Related]
8. [The control of chemotherapy-induced nausea and vomiting].
Shinkai T; Saijo N; Sawamura N; Funaki U; Takahashi S; Yokoyama S; Fujita J; Futami H; Sasaki Y; Shimizu E
Gan No Rinsho; 1985 Jun; 31(7):779-91. PubMed ID: 3897622
[TBL] [Abstract][Full Text] [Related]
9. Optimising antiemesis in cancer chemotherapy: efficacy of continuous versus intermittent infusion of high dose metoclopramide in emesis induced by cisplatin.
Warrington PS; Allan SG; Cornbleet MA; MacPherson JS; Smyth JF; Leonard RC
Br Med J (Clin Res Ed); 1986 Nov; 293(6558):1334-7. PubMed ID: 3790968
[TBL] [Abstract][Full Text] [Related]
10. Prevention of cisplatin-induced delayed emesis: still unsatisfactory. Italian Group for Antiemetic Research.
Support Care Cancer; 2000 May; 8(3):229-32. PubMed ID: 10789965
[TBL] [Abstract][Full Text] [Related]
11. Comparative evaluation of two outpatient antiemetic regimens for cancer chemotherapy.
Pruitt BT; Justice RL; Periman P
Tex Med; 1985 Jul; 81(7):44-5. PubMed ID: 3898458
[No Abstract] [Full Text] [Related]
12. [Clinical evaluation of granisetron injection against nausea and vomiting induced by anticancer drugs including cisplatin].
Yoshiya N; Kodama S; Tanaka K; Hataya I; Tokunaga A; Takeuchi Y; Hanaoka J; Yanase T; Takahashi T; Maruhashi T
Gan To Kagaku Ryoho; 1994 Aug; 21(10):1641-6. PubMed ID: 8060140
[TBL] [Abstract][Full Text] [Related]
13. A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesis.
Madej G; Krzakowski M; Pawinski A; Lasota W; Rogowski W; Skoneczna I
Semin Oncol; 1994 Oct; 21(5 Suppl 9):3-6. PubMed ID: 9113119
[TBL] [Abstract][Full Text] [Related]
14. Parkinsonism following i.v. administration of high-dose metoclopramide used as an antiemetic agent during cancer chemotherapy.
Markman M; Newman DR; Hawkins RS
Cancer Treat Rep; 1985 Mar; 69(3):341-2. PubMed ID: 4038919
[No Abstract] [Full Text] [Related]
15. Antiemetics for patients treated with antitumor chemotherapy.
Williams CJ; Bolton A; de Pemberton R; Whitehouse JM
Cancer Clin Trials; 1980; 3(4):363-7. PubMed ID: 6253100
[TBL] [Abstract][Full Text] [Related]
16. [The antiemetic effect and clinical evaluation of metoclopramide alone and combined with betamethasone in children with malignant tumor].
Hatae Y; Takeda T; Nakadate H; Hatayama Y; Kishino T; Ogawa Y
Gan To Kagaku Ryoho; 1989 Nov; 16(11):3639-42. PubMed ID: 2817913
[No Abstract] [Full Text] [Related]
17. Pharmacoeconomic analysis of ondansetron versus metoclopramide for cisplatin-induced nausea and vomiting.
Zbrozek AS; Cantor SB; Cardenas MP; Hill DP
Am J Hosp Pharm; 1994 Jun; 51(12):1555-63. PubMed ID: 8092156
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of the antiemetic action of metoclopramide against cisplatin-induced emesis by transdermal electrical nerve stimulation.
Saller R; Hellenbrecht D; Bühring M; Hess H
J Clin Pharmacol; 1986 Feb; 26(2):115-9. PubMed ID: 3512620
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of postoperative nausea and vomiting with ondansetron in patients administered anti-neoplastic agents].
Morimoto Y; Nakamura M; Tamura T; Kunii T; Shimizu K; Miyauchi Y
Masui; 1996 Sep; 45(9):1096-9. PubMed ID: 8905945
[TBL] [Abstract][Full Text] [Related]
20. A pilot study of high-dose domperidone as an antiemetic in patients treated with cisplatin.
Tonato M; Roila F; del Favero A; Tognoni G; Franzosi MG; Pampallona S
Eur J Cancer Clin Oncol; 1985 Jul; 21(7):807-10. PubMed ID: 4043169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]